✦ LIBER ✦

Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients

✍ Scribed by Coleman, C.I.; Limone, B.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CRT-32 Universal Ticagrelor Versus Assay

✍ Limone, Brendan L.; Coleman, Craig I. 📂 Article 📅 2013 🏛 American College of Cardiology 🌐 English ⚖ 95 KB

Cost-Effectiveness of Universal and Plat

✍ Coleman, Craig I.; Limone, Brendan L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 336 KB

COST-EFFECTIVENESS OF UNIVERSAL OR PHENO

✍ Coleman, Craig I.; Limone, Brendan; Lee, Soyon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Ticagrelor versus Genotype-Driven Antipl

✍ Daniel J. Crespin; Jerome J. Federspiel; Andrea K. Biddle; Daniel E. Jonas; Jose 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 913 KB

COST-EFFECTIVENESS OF UNIVERSAL OR GENOT

✍ Soyon Lee; Asha Dhamija; Katelyn Parsons; Matthew King; Rajbir Kaur; Matthew Rob 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRI

✍ DJ Crespin; JJ Federspiel; AK Biddle; D Jonas; SC Stearns; JS Rossi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB